EUFOREA presents its last masterclass of the year. The Symposium on 'Maximizing the Therapeutic Response in Allergic Rhinitis' is an exclusive, invitation-only masterclass in Kuala Lumpur that brings together leading experts to discuss the latest advances and evolving standards in the management of allergic rhinitis (AR). Through a focused series of lectures, participants will gain an up-to-date understanding of current clinical guidelines, the evidence supporting combined therapeutic approaches, and the importance of adopting a holistic perspective to optimize patient outcomes.
Main objectives of this masterclass include:
👉 This masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) with 1.0 European CME credits (ECMEC) and is valid for 6 months from the event date.
The 'Maximizing the Therapeutic Response in Allergic Rhinitis' in Kuala Lumpur, Malaysia, 09/12/2025 - 09/12/2025, organised by The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
